Sun Pharma gets US FDA approval to market generic Cerebyx

20 Mar 2008

1

Mumbai: Sun Pharmaceutical Industries Ltd has received approval from the US Food and Drug Administration (US FDA) to market Fosphenytoin sodium injections.

Fosphenytoin is a generic variant of Pfizer Inc's Cerebyx.

Cerebyx is a water-soluble phenytoin prodrug used in hospitals for the treatment of epileptic seizures during neurosurgery. Cerebyx vial contains 75 mg / ml fosphenytoin sodium, hence it is referred as a fosphenytoin sodium injection. Cerebyx is a clear, colourless to pale yellow, sterile solution.

Fosphenytoin sodium injections has annual sales of $15 million in the US, Sun Pharma said in a statement.

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers